NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

ViiV logo
ViiV Healthcare, a global HIV specialty company with U.S. headquarters in RTP, says preliminary clinical trial results show its every-other-month injectable is more effective than the current standard-of-care daily oral medication in preventing HIV.
LabCorp logo
LabCorp is offering employers COVID-19 testing solutions, including its at-home collection test kit, its new fingerstick antibody blood test, and in the fall, flu vaccination services.
Orion logo
Orion Integrated Biosciences, a Kansas-based biodefense company with a growing presence in North Carolina, plans to use artificial intelligence to design vaccines to fight COVID-19.
Grifols in Clayton
If you’ve been diagnosed with the COVID-19 coronavirus and have recovered, you can help researchers find a potential treatment for the disease by donating at one of Grifols' plasma collection sites.
TII logo
A new North Carolina medical software company, Translational Imaging Innovations, is developing tools to help scientists and doctors get medical innovations into the eye clinic faster, with less frustration and at a lower cost.
Opaganib bottle
RedHill Biopharma has received approval to test its investigational COVID-19 drug, opaganib, in the United States.
Microgrant logo
The Asheville Impact Micro Grant, a Venture Asheville program, will award $5,000 to five new startups in Haywood or Buncombe County this year.
CDC photo of coronavirus
UNC is the highest-ranked U.S. university for coronavirus research, according to Microsoft Academic, a public search engine for scholarly publications, journals and other literature.
Alexandria Center for Ag Tech
Two of the seven Alexandria LaunchLab $100,000 AgTech Innovation Prize finalists, TreeCo and TerMir, are based in the Triangle.
Researchers at UNCG are developing a unique new weapon to combat one of the major causes of honeybee declines: the parasitic mite called the Varroa destructor and the numerous viruses and other harmful pathogens it transmits.
NCBiotech awarded 13 grants and loans totaling $1.8 million to universities and bioscience companies in the third quarter of its current fiscal year.
Grifols' 233-acre manufacturing site in Clayton.
Grifols is collecting a blood product from recovered COVID-19 patients to develop a possible treatment for the coronavirus disease.
Shutterstock image of woman doing fingertip test
Four North Carolina universities have teamed up to win a $5.7 million federal grant for diabetes research.
Venture Connect Online logo
CED's Venture Connect Online starts today and runs for the next three weeks, giving over 90 growth-stage companies exposure to potential investors from around the world.
Banner logo
Banner Life Sciences, a High Point pharmaceutical company, has gained final regulatory approval of a drug for treating multiple sclerosis.